Phase II Study with Symadex (C-1311) in Patients with Metastatic Colorectal Cancer after Oxaliplatin and/or Irinotecan Failure
Ontology highlight
ABSTRACT: Primary objectives: Evaluate the overall response rate (CR+PR) using RECIST criteria.
Primary: Overall response rate (ORR) = complete response (CR) + partial response (PR) using RECIST criteria.
Secondary: Time to progression (TTP) and duration of response.
DISEASE(S): Metastatic Colorectal Cancer
PROVIDER: 2518286 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA